Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Myelodysplastic Syndromes: A More Global 5-Hydroxymethylcytosine Deficiency Disorder Than Suggested By the Presence of TET2 Mutations

Carmelo Gurnari, Simona Pagliuca, Yihong Guan, Courtney E. Hershberger, Ying Ni, Jaymeson Gordon, Hetty E. Carraway, Richard A Padgett, Diego Coutinho, Ilana Zalcberg, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim, Sr., Mark D. Minden, Joop H. Jansen, Babal K. Jha, Torsten Haferlach, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2021) 138 (Supplement 1): 3665.

https://doi.org/10.1182/blood-2021-145949

Published: 2021

Journal Articles

Droplet Digital PCR Reliably Detects a Single Copy of BCR-ABL1

Jaspal Kaeda, PhD FRCPath, Simone Bonecker, Frauke Ringel, Michaela Schwarz, Bernd Dörken, Ilana Zalcberg, Philipp Le Coutre, MD

Blood (2015) 126 (23): 2784.

https://doi.org/10.1182/blood.V126.23.2784.2784

Published: 2015

Journal Articles

MSI2 and TGFβR1 Expression Levels in CML Patients and Hematopoietic Cell Lines

Jaspal S Kaeda, PhD, Simone Bonecker, Iris von Wunsch-Rolshoven, Frauke Ringel, PhD, Michaela Schwarz, Bernd Dörken, MD, Ilana Zalcberg, Philipp le Coutre, MD

Blood (2014) 124 (21): 4533.

https://doi.org/10.1182/blood.V124.21.4533.4533

Published: 2014

Journal Articles

MSI2 and HOXA9 Expression Is Significantly Increased in Patients with Primary Myelofibrosis

Jaspal S Kaeda, PhD, Jackline Ayres-Silva, Leila Amini, BSc, Iris von Wunsch-Rolshoven, Frauke Ringel, PhD, Michaela Schwarz, MD, Bernd Dörken, MD, Ilana Zalcberg, Philipp le Coutre, MD

Blood (2014) 124 (21): 1868.

https://doi.org/10.1182/blood.V124.21.1868.1868

Published: 2014

Journal Articles

Detection of BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia Patients Treated with Tirosin-Kinase Inhibitors

Gonzalo Manrique, Roberta Bittencout, Verónica Pérez, Vanesa Sholl, Monica Cappetta, MsC, Noel Zubillaga, MD, Rocio Hassan, Susana Boschi, Victoria Elizondo, Hector Seuanez, PhD, Ilana Zalcberg, PhD, Lem Martinez, MD, M. Rosario Uri arte Escuder, PhD

Blood (2008) 112 (11): 4261.

https://doi.org/10.1182/blood.V112.11.4261.4261

Published: 2008

Journal Articles

Late Responders to Imatinib: Is Timing of Achievement of Complete Cytogenetic and Molecular Responses the Same in Previously Treated as Compared to the Newly Diagnosed CML Patients?

Vanesa Scholl, Roberta Bitencourt, Arthur Moellmann, Rocio Hassan, Moises Rocha, Jane Dobbin, Ilana Zalcberg

Blood (2008) 112 (11): 4266.

https://doi.org/10.1182/blood.V112.11.4266.4266

Published: 2008

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Myelodysplastic Syndromes: A More Global 5-Hydroxymethylcytosine Deficiency Disorder Than Suggested By the Presence of TET2 Mutations

Droplet Digital PCR Reliably Detects a Single Copy of BCR-ABL1

MSI2 and TGFβR1 Expression Levels in CML Patients and Hematopoietic Cell Lines

MSI2 and HOXA9 Expression Is Significantly Increased in Patients with Primary Myelofibrosis

Detection of BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia Patients Treated with Tirosin-Kinase Inhibitors

Late Responders to Imatinib: Is Timing of Achievement of Complete Cytogenetic and Molecular Responses the Same in Previously Treated as Compared to the Newly Diagnosed CML Patients?

Email alerts

ASH Publications

American Society of Hematology

Update search

Myelodysplastic Syndromes: A More Global 5-Hydroxymethylcytosine Deficiency Disorder Than Suggested By the Presence of TET2 Mutations

Droplet Digital PCR Reliably Detects a Single Copy of BCR-ABL1

MSI2 and TGFβR1 Expression Levels in CML Patients and Hematopoietic Cell Lines

MSI2 and HOXA9 Expression Is Significantly Increased in Patients with Primary Myelofibrosis

Detection of BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia Patients Treated with Tirosin-Kinase Inhibitors

Late Responders to Imatinib: Is Timing of Achievement of Complete Cytogenetic and Molecular Responses the Same in Previously Treated as Compared to the Newly Diagnosed CML Patients?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only